Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong · Delayed Price · Currency is HKD 26.96
+0.66 (2.51%)
Oct 22, 2026, 4:08 PM HKT
HKG:3378 Market Cap
HKG:3378 has a market cap or net worth of 3.67 billion as of October 21, 2026. It is the 15,336th most valuable company in the world and the 685th biggest in Hong Kong.
Market Cap
3.67B
Enterprise Value
3.19B
Revenue
84.28K
Global Rank
Country Rank
#685 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since December 23, 2025, HKG:3378's market cap has increased from 2.34B to 3.67B, an increase of 56.74%. That is a compound annual growth rate of 71.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 3.67B | 68.71% |
| Dec 31, 2025 | 2.18B | -7.09% |
| Dec 23, 2025 | 2.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abbisko Cayman | 5.02B |
| CK Life Sciences Int'l., (Holdings) | 4.90B |
| Jacobio Pharmaceuticals Group | 4.13B |
| Ocumension Therapeutics | 3.91B |
| TransThera Sciences (Nanjing) | 3.70B |
| Mirxes Holding Company | 3.66B |
| Qyuns Therapeutics | 3.62B |
| Beijing Luzhu Biotechnology | 3.04B |